上海，2025年7月7日 – 近日，藥明康德在摩根士丹利資本國(guó)際公司（MSCI）最新公布的環(huán)境、社會(huì)及管治（ESG）年度評(píng)級(jí)結(jié)果中，首次獲評(píng)最高評(píng)級(jí)“AAA”級(jí)，成為A股生命健康行業(yè)中首家獲此認(rèn)可的企業(yè)。這一成就充分彰顯了公司始終踐行可持續(xù)發(fā)展的堅(jiān)定承諾，更體現(xiàn)了以負(fù)責(zé)任方式為客戶創(chuàng)造長(zhǎng)期價(jià)值、共建健康未來的決心。

MSCI是全球領(lǐng)先的投資調(diào)研公司，為機(jī)構(gòu)投資者提供股票指數(shù)和投資組合績(jī)效分析。MSCI ESG評(píng)級(jí)旨在衡量一家公司對(duì)長(zhǎng)期的、與財(cái)務(wù)相關(guān)的ESG風(fēng)險(xiǎn)抵御能力。MSCI ESG評(píng)級(jí)結(jié)果從“AAA”（最高）至“CCC”（最低）共分為7個(gè)等級(jí)，其中“AAA”和“AA”級(jí)被視為行業(yè)領(lǐng)先者。

藥明康德憑借在產(chǎn)品安全與質(zhì)量、人力資本開發(fā)、企業(yè)治理等議題的卓越表現(xiàn)，在本次評(píng)估周期中獲得“AAA”領(lǐng)導(dǎo)力評(píng)級(jí)。此前，公司已于2021年至2024年期間連續(xù)4年保持“AA”評(píng)級(jí)，體現(xiàn)了其在ESG績(jī)效方面的持續(xù)卓越表現(xiàn)。

“我們很榮幸獲得MSCI ESG最高評(píng)級(jí)，這是對(duì)藥明康德將可持續(xù)發(fā)展融入公司運(yùn)營(yíng)并為社會(huì)各方創(chuàng)造長(zhǎng)期價(jià)值的高度認(rèn)可。”藥明康德聯(lián)席首席執(zhí)行官、ESG委員會(huì)主席楊青博士表示，“藥明康德將持續(xù)追求高質(zhì)量的發(fā)展，通過其獨(dú)特的CRDMO賦能平臺(tái)，助力客戶加速突破性療法早日問世，造福全球病患。”

作為創(chuàng)新的賦能者、客戶信賴的合作伙伴以及全球健康產(chǎn)業(yè)的貢獻(xiàn)者，藥明康德和大多數(shù)客戶一樣，積極踐行對(duì)可持續(xù)發(fā)展的承諾，并將其先進(jìn)的理念融入到公司全球運(yùn)營(yíng)的方方面面，不斷為社會(huì)和環(huán)境帶來積極的影響。截至目前，公司已連續(xù)四年入選道瓊斯可持續(xù)發(fā)展指數(shù)（DJSI）；連續(xù)三年獲得CDP氣候變化“A-”級(jí)領(lǐng)導(dǎo)力評(píng)級(jí)、Morningstar Sustainalytics ESG“行業(yè)最高評(píng)級(jí)”及“區(qū)域最高評(píng)級(jí)”；首次獲得CDP水安全“A”級(jí)領(lǐng)導(dǎo)力評(píng)級(jí)、EcoVadis企業(yè)社會(huì)責(zé)任評(píng)級(jí)“金牌”認(rèn)證。

此外，為進(jìn)一步深化可持續(xù)發(fā)展承諾，藥明康德持續(xù)拓展全球責(zé)任實(shí)踐。公司溫室氣體減排近期目標(biāo)成功通過了SBTi審核認(rèn)證。同時(shí)，公司已加入聯(lián)合國(guó)全球契約組織（UNGC），承諾支持全球契約十項(xiàng)原則；并加入制藥供應(yīng)鏈倡議（PSCI），成為PSCI供應(yīng)商合作伙伴。

關(guān)于藥明康德

藥明康德（股票代碼：603259.SH/2359.HK）是全球醫(yī)藥及生命科學(xué)行業(yè)值得信賴的合作伙伴和重要貢獻(xiàn)者，致力于通過提供一體化、端到端的新藥研發(fā)和生產(chǎn)服務(wù)，推動(dòng)全球醫(yī)藥健康創(chuàng)新。公司在亞洲、歐洲、北美等地均設(shè)有運(yùn)營(yíng)基地，依托獨(dú)特的“CRDMO”業(yè)務(wù)模式，不斷降低研發(fā)門檻，助力客戶提升研發(fā)效率，為患者帶來突破性的治療方案。目前，公司的賦能平臺(tái)正承載著來自全球30多個(gè)國(guó)家的約6,000家合作伙伴的研發(fā)創(chuàng)新項(xiàng)目，致力于將更多新藥、好藥帶給全球病患，早日實(shí)現(xiàn)“讓天下沒有難做的藥，難治的病”的愿景。更多信息，請(qǐng)?jiān)L問公司網(wǎng)站：www.wuxiapptec.com

WuXi AppTec Receives MSCI ESG AAA Leader Rating

SHANGHAI, July 7, 2025 - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced it has achieved the AAA rating – the highest level – from MSCI in its latest annual Environmental, Social, and Governance (ESG) ratings. This is the first time WuXi AppTec has achieved the AAA rating, making it the first A-share listed company in the life science industry to reach this milestone. This achievement underscores WuXi AppTec’s enduring commitment to sustainability and its belief in driving long-term value through responsible growth for a healthier future.

MSCI is a leading provider of critical decision support tools and services for the global investment community. Its ESG ratings assess companies on financially relevant sustainability risks and opportunities, enabling investors to better understand a company’s sustainable development performance and make more informed investment decisions. The MSCI ESG rating system includes seven levels, from AAA (highest) to CCC (lowest), with AAA and AA considered leader ratings.

WuXi AppTec earned the AAA leader rating for its outstanding performance in areas such as Product Safety and Quality, Human Capital Development, and Corporate Governance. Previously, the company maintained an AA rating for four consecutive years, demonstrating consistent leadership in ESG performance.

“We are honored to receive MSCI’s highest ESG rating,” said Dr. Steve Yang, Co-CEO of WuXi AppTec and Chairman of WuXi AppTec’s ESG Committee. “This recognition reflects our commitment to integrating sustainability across our operations and reaffirms the long-term value we strive to create for all stakeholders. We will continue to pursue high-quality growth through our CRDMO platform and support our customers in developing and delivering innovative therapies to patients worldwide.”

As an enabler of innovation, a trusted partner, and a contributor to the global pharmaceutical and life sciences industry, WuXi AppTec strategically integrates sustainability priorities like most of the customers into its global business operations. The Company has been included in the Dow Jones Sustainability Index (DJSI) for four consecutive years, received an A- Leadership rating in the CDP Climate Change assessment for three years, and has been recognized as an Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics. WuXi AppTec has also earned an A Leadership rating in the CDP Water Security assessment and a Gold Medal in the EcoVadis sustainability rating.

To further its sustainability commitment, WuXi AppTec has received Science Based Targets initiative (SBTi) validation for its near-term emissions reduction targets. The Company is also a participant in the United Nations Global Compact (UNGC), supporting its ten principles, and a supplier partner of the Pharmaceutical Supply Chain Initiative (PSCI).

About WuXi AppTec

WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer an integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at www.wuxiapptec.com.

免責(zé)聲明：本文僅作信息交流之目的，文中觀點(diǎn)不代表藥明康德立場(chǎng)，亦不代表藥明康德支持或反對(duì)文中觀點(diǎn)。本文也不是治療方案推薦。如需獲得治療方案指導(dǎo)，請(qǐng)前往正規(guī)醫(yī)院就診。

版權(quán)說明：歡迎個(gè)人轉(zhuǎn)發(fā)至朋友圈，謝絕媒體或機(jī)構(gòu)未經(jīng)授權(quán)以任何形式轉(zhuǎn)載至其他平臺(tái)。轉(zhuǎn)載授權(quán)請(qǐng)?jiān)凇杆幟骺档隆刮⑿殴娞?hào)回復(fù)“轉(zhuǎn)載”，獲取轉(zhuǎn)載須知。